The public-private consortium includes 16 entities and has received the highest score of all projects submitted in the R&D Missions in Artificial Intelligence competition.

The OPTIMA project aims to advance treatments for prostate, breast and lung cancer by applying cutting-edge technologies.

The OPTIMA project aims to advance treatments for prostate, breast and lung cancer by applying cutting-edge technologies

The HARMONY Alliance, comprised of the IMI HARMONY and HARMONY PLUS projects, covers the full spectrum of research into hematologic neoplasms and seeks to facilitate the development of more effective treatments for patients affected by this type of disease

The Alliance is applying advanced analytical technologies, big data and artificial intelligence, developed by GMV, to draw the first European map of blood tumors

The HARMONY database will use the data shared to date and aims to function as a tool for designing new clinical tests and reduce their costs, with the corresponding benefits to society

The Alliance is applying advanced analytical technologies, big data and artificial intelligence, developed by GMV, to draw the first European map of blood tumors.